Jun 09, 2021 / 01:40PM GMT
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst
Good morning, everyone. This is Matt Sykes, Senior Life Sciences Tools and Diagnostics analyst at Goldman Sachs. And I have the pleasure of welcoming the Veracyte management team to our conference.
With us today, we have Bonnie Anderson, the Executive Chairperson; and Marc Stapley, the Chief Executive Officer from Veracyte. Thank you both for joining us. We're really happy to have you here.
Marc A. Stapley - Veracyte, Inc. - CEO
Thank you, Matt. Pleasure to be here.
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst
Great. Maybe there's been a lot of things going on with Veracyte lately. A lot of exciting news. You guys have been very busy. I thought maybe what we'd start out, Marc, if you can kind of take us through sort of a bit of the history and the journey that Veracyte has been going through, leading us up to where we are today.
Marc A. Stapley -
Veracyte Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Feb 29, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers